Cargando...
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs()
Histone deacetylases (HDACs) are validated drug targets for cancer treatment. Increased HDAC isozyme selectivity and novel strategies to inhibit HDAC activity could lead to safer and more effective drug candidates. Nonetheless, it is quite challenging to develop isozyme-specific HDACi due to the hig...
Gardado en:
| Publicado en: | Chem Commun (Camb) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7654701/ https://ncbi.nlm.nih.gov/pubmed/32840532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0cc03243c |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|